Cognitive Functioning After Radiotherapy or Chemoradiotherapy for Head-and-Neck Cancer

Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Haddad, 2008, Recent advances in head and neck cancer, N Engl J Med, 359, 1143, 10.1056/NEJMra0707975 Pignon, 2009, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients, Radiother Oncol, 92, 4, 10.1016/j.radonc.2009.04.014 Bernier, 2009, Molecular therapy in head and neck oncology, Nat Rev Clin Oncol, 6, 266, 10.1038/nrclinonc.2009.40 Bonner, 2006, Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck, N Engl J Med, 354, 567, 10.1056/NEJMoa053422 Bourhis, 2006, Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis, Lancet, 368, 843, 10.1016/S0140-6736(06)69121-6 Hermelink, 2007, Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study, Cancer, 109, 1905, 10.1002/cncr.22610 van Dam, 1998, Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy, J Natl Cancer Inst, 90, 210, 10.1093/jnci/90.3.210 Von Ah, 2009, Cognitive function in breast cancer survivors compared to healthy age- and education-matched women, Clin Neuropsychol, 23, 661, 10.1080/13854040802541439 Wefel, 2004, The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial, Cancer, 100, 2292, 10.1002/cncr.20272 Wefel, 2004, “Chemobrain” in breast carcinoma?: A prologue, Cancer, 101, 466, 10.1002/cncr.20393 Cull, 1994, Neurological and cognitive impairment in long-term survivors of small cell lung cancer, Eur J Cancer, 30A, 1067, 10.1016/0959-8049(94)90458-8 Grosshans, 2008, Neurocognitive function in patients with small cell lung cancer: Effect of prophylactic cranial irradiation, Cancer, 112, 589, 10.1002/cncr.23222 Johnson, 1990, Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: Further follow-up of 6- to 13-year survivors, J Clin Oncol, 8, 48, 10.1200/JCO.1990.8.1.48 Komaki, 1995, Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation, Int J Radiat Oncol Biol Phys, 33, 179, 10.1016/0360-3016(95)00026-U van Oosterhout, 1995, Follow-up of cognitive functioning in patients with small cell lung cancer, Int J Radiat Oncol Biol Phys, 31, 911, 10.1016/0360-3016(94)00579-6 Bosma, 2008, Synchronized brain activity and neurocognitive function in patients with low-grade glioma: A magnetoencephalography study, Neuro-Oncology, 10, 734, 10.1215/15228517-2008-034 Kramer, 1997, Neuropsychological sequelae of medulloblastoma in adults, Int J Radiat Oncol Biol Phys, 38, 21, 10.1016/S0360-3016(96)00592-5 Laack, 2005, Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study, Int J Radiat Oncol Biol Phys, 63, 1175, 10.1016/j.ijrobp.2005.04.016 Correa, 2008, Longitudinal cognitive follow-up in low grade gliomas, J Neurooncol, 86, 321, 10.1007/s11060-007-9474-4 Klein, 2002, Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study, Lancet, 360, 1361, 10.1016/S0140-6736(02)11398-5 Surma-aho, 2001, Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients, Neurology, 56, 1285, 10.1212/WNL.56.10.1285 Postma, 2002, Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma, Neurology, 59, 121, 10.1212/WNL.59.1.121 Moretti, 2005, Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: A comparison with vascular dementia, J Neurol Sci, 10.1016/j.jns.2004.11.027 Armstrong, 2002, Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings, Neurology, 59, 40, 10.1212/WNL.59.1.40 Hua, 1998, Neuropsychological function in patients with nasopharyngeal carcinoma after radiotherapy, J Clin Exp Neuropsychol, 20, 684, 10.1076/jcen.20.5.684.1131 Lam, 2003, Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma, J Neuropsychiatry Clin Neurosci, 15, 90, 10.1176/appi.neuropsych.15.1.90 Lee, 1989, Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma, J Neurol Neurosurg Psychiatry, 52, 488, 10.1136/jnnp.52.4.488 Seruga, 2008, Cytokines and their relationship to the symptoms and outcome of cancer, Nat Rev Cancer, 8, 887, 10.1038/nrc2507 Pries, 2006, Role of cytokines in head and neck squamous cell carcinoma, Exp Rev Anticancer Ther, 6, 1195, 10.1586/14737140.6.9.1195 McCaffrey, 2007, Alcoholism, depression, and abnormal cognition in head and neck cancer: A pilot study, Otolaryngol Head Neck Surg, 136, 92, 10.1016/j.otohns.2006.06.1275 Weschler, 1997 Weschler, 1999 Delis, 2001 Kaplan, 2000 Brandt, 2001 Benedict, 1997 Reitan, 1985 Klove, 1963, Grooved Pegboard Test, Med Clin North Am, 46, 1647 Lai, 2006 Jacobs, 2007, Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients, J Pain Symptom Manage, 33, 13, 10.1016/j.jpainsymman.2006.06.011 Ringash, 2001, A structured review of quality of life instruments for head and neck cancer patients, Head Neck, 23, 201, 10.1002/1097-0347(200103)23:3<201::AID-HED1019>3.0.CO;2-M Yellen, 1997, Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system, J Pain Symptom Manage, 13, 63, 10.1016/S0885-3924(96)00274-6 Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x Lezak, 2004 van der Schroeff, 2007, The effect of age on survival and quality of life in elderly head and neck cancer patients: A long-term prospective study, Eur Arch Otorhinolaryngol, 264, 415, 10.1007/s00405-006-0203-y Abendstein, 2005, Quality of life and head and neck cancer: A 5 year prospective study, Laryngoscope, 115, 2183, 10.1097/01.MLG.0000181507.69620.14 Chaukar, 2009, Quality of life in head and neck cancer survivors: A cross-sectional survey, Am J Otolaryngol, 30, 176, 10.1016/j.amjoto.2008.05.001 Yuen, 2008, Radiation dose, driving performance, and cognitive function in patients with head and neck cancer, Radiother Oncol, 87, 304, 10.1016/j.radonc.2008.03.020 Yuen, 2007, Driving performance in patients with cancer in the head and neck region: A pilot study, Arch Otolaryngol Head Neck Surg, 133, 904, 10.1001/archotol.133.9.904 Yuen, 2007, Driving behaviors in patients with head and neck cancer during and after cancer treatment: A preliminary report, Head Neck, 29, 675, 10.1002/hed.20567 Taylor, 2004, Disability in patients with head and neck cancer, Arch Otolaryngol Head Neck Surg, 130, 764, 10.1001/archotol.130.6.764 El-Deiry, 2005, Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer, Arch Otolaryngol Head Neck Surg, 131, 879, 10.1001/archotol.131.10.879 Abayomi, 2002, Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors, Acta Oncol, 41, 346, 10.1080/028418602760169389 el-Shazly, 1989, Histopathological study into side-effect toxicity of some drugs used in treatment of cancer, Arch Exp Veterinarmed, 43, 319 Vihinen, 2003, Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue, Acta Oncol, 42, 237, 10.1080/02841860310010754 Gorman, 1989, Focal encephalopathy after cisplatin therapy, Med J Aust, 150, 399, 10.5694/j.1326-5377.1989.tb136535.x Kondo, 1996, Severe acute metabolic acidosis and Wernicke's encephalopathy following chemotherapy with 5-fluorouracil and cisplatin: case report and review of the literature, Jpn J Clin Oncol, 26, 234, 10.1093/oxfordjournals.jjco.a023220 Berman, 1980, Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man, Cancer, 45, 764, 10.1002/1097-0142(19800215)45:4<764::AID-CNCR2820450425>3.0.CO;2-G Cattaneo, 1988, Transient blindness and seizure associated with cisplatin therapy, J Cancer Res Clin Oncol, 114, 528, 10.1007/BF00391507 Shilling, 2005, The effects of adjuvant chemotherapy on cognition in women with breast cancer—Preliminary results of an observational longitudinal study, Breast, 14, 142, 10.1016/j.breast.2004.10.004 Cimprich, 2005, Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer, Psychooncology, 14, 70, 10.1002/pon.821 Schagen, 1999, Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma, Cancer, 85, 640, 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G Castellon, 2004, Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen, J Clin Exp Neuropsychol, 26, 955, 10.1080/13803390490510905